SATURNUS BIO Trademark

Trademark Overview


On Thursday, November 14, 2024, a trademark application was filed for SATURNUS BIO with the United States Patent and Trademark Office. The USPTO has given the SATURNUS BIO trademark a serial number of 98853488. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, May 19, 2025. This trademark is owned by Saturnus Bio, Inc.. The SATURNUS BIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

therapeutic pharmaceuticals for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular and muscle diseases; biological preparations for the prevention and treatment of cardiovascular and muscle diseases; biological therapies for the prevention and treatment of cardiovascular and muscle diseases

scientific research for medical purposes in the field of cardiovascular and muscle diseases; research and development of therapeutics for the treatment of cardiovascular and muscle diseases; research and development in the field of small molecule drug discovery; medical and scientific research in the field of cardiovascular and muscle diseases; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; drug discovery services; pharmaceutical research and development services; research and development in the field of precision medicine
saturnus bio

General Information


Serial Number98853488
Word MarkSATURNUS BIO
Filing DateThursday, November 14, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, May 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicestherapeutic pharmaceuticals for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular and muscle diseases; biological preparations for the prevention and treatment of cardiovascular and muscle diseases; biological therapies for the prevention and treatment of cardiovascular and muscle diseases
Goods and Servicesscientific research for medical purposes in the field of cardiovascular and muscle diseases; research and development of therapeutics for the treatment of cardiovascular and muscle diseases; research and development in the field of small molecule drug discovery; medical and scientific research in the field of cardiovascular and muscle diseases; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; drug discovery services; pharmaceutical research and development services; research and development in the field of precision medicine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 14, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSaturnus Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94104

Trademark Events


Event DateEvent Description
Thursday, November 14, 2024NEW APPLICATION ENTERED
Saturday, April 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 19, 2025NON-FINAL ACTION WRITTEN
Monday, May 19, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 19, 2025NON-FINAL ACTION E-MAILED
Friday, May 9, 2025ASSIGNED TO EXAMINER